Neoadjuvant chemoimmunotherapy as a potential therapeutic option in NSCLC UICC stage IIIA with multilevel N2 disease

por Menghesha, Hruy, Doerr, Fabian, Schlachtenberger, Georg, Estremadoyro, Andres Amorin, Töpelt, Karin, Wahlers, Thorsten, Hekmat, Khosro, Heldwein, Matthias
Publicado 2022